DHR stock forecast
Our latest prediction for Danaher Corp.'s stock price was made on the Feb. 3, 2020 when the stock price was at 161.00$.
In the short term (2weeks), DHR's stock price should underperform the market by -0.58%. During that period the price should oscillate between -4.79% and +3.11%.
In the medium term (3months), DHR's stock price should outperform the market by 1.45%. During that period the price should oscillate between -10.10% and +8.72%.Get email alerts
About Danaher Corp.
Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.
At the moment the company generates 20437M USD in revenues.
On its last earning announcement, the company reported a profit of 3.38$ per share.
The book value per share is 38.89$
Three months stock forecastFeb. 3, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|